A board asks for faster AI adoption. Legal wants guardrails. Security sees data leakage risk. Compliance sees a policy gap that will be difficult to defend later. That is usually where the real question starts: how should AI be regulated in a way that supports innovation without creating unmanaged exposure?
For regulated organizations, the answer is not a single law, agency, or control set. AI regulation should work as a layered system. Governments should set minimum standards for safety, transparency, accountability, and rights protection. Sector regulators should apply those standards to the realities of healthcare, finance, employment, and critical infrastructure. Organizations should then operationalize those expectations through governance, vendor oversight, technical controls, and documented decision-making.
That structure matters because AI risk is not theoretical. In healthcare and regulated SaaS environments, poor controls can lead to privacy violations, biased outputs, unsafe automation, security incidents, and business decisions that cannot be explained when a regulator, customer, or board asks hard questions.
How should AI be regulated at a high level?
AI should be regulated based on risk, not hype. A model that drafts internal meeting notes does not require the same scrutiny as a system used in clinical decision support, underwriting, fraud detection, identity verification, or workforce screening. Treating all AI the same creates either excessive friction or dangerous gaps.
A sound regulatory approach starts by separating low-risk use from high-impact use. Low-risk systems may only require baseline transparency, security review, and acceptable-use controls. High-impact systems should face stronger requirements around testing, monitoring, human oversight, data governance, incident response, and formal accountability.
This is where many policy debates lose credibility with operators. Broad calls for either unrestricted innovation or sweeping prohibition do not help a leadership team deciding whether a generative AI tool can access patient-adjacent data, summarize support tickets, or support internal coding workflows. Effective regulation has to be specific enough to govern actual business use.
The right model is risk-based, sector-aware, and enforceable
Risk-based regulation is the most practical path because AI harms are uneven. Some failures are inconvenient. Others affect health outcomes, civil rights, consumer protection, financial access, or public safety. Regulation should reflect that difference.
Sector awareness is just as important. Healthcare organizations operate under privacy, security, and documentation expectations that are already substantial. AI regulation in that context should align with existing obligations instead of sitting beside them as a disconnected policy layer. If an AI system touches protected health information, supports patient engagement, influences care operations, or relies on third-party models, the governance standard should reflect HIPAA exposure, vendor risk, data minimization expectations, and auditability.
Enforceability is the third requirement. A regulation that cannot be translated into policy, process, evidence, and control ownership is not useful. Leadership teams need rules that can be implemented through procurement gates, architecture reviews, model inventories, use case approvals, contract language, and monitoring routines. If the standard cannot survive contact with procurement, security, legal, and operations, it will fail in practice.
What AI regulation should require from organizations
The most effective regulatory frameworks do not try to prescribe every technical detail. They establish outcomes and require organizations to demonstrate control. In practice, that means five things.
First, organizations should maintain an inventory of AI use cases, models, and third-party providers. You cannot govern what you cannot identify. For many companies, the largest AI risk is not a flagship deployment. It is fragmented adoption across departments with inconsistent review and no central visibility.
Second, regulation should require documented risk classification. Each AI use case should be assessed based on data sensitivity, decision impact, user population, automation level, and regulatory exposure. This is what allows governance to scale. Without classification, every review becomes improvised.
Third, organizations should be required to establish clear accountability. Someone should own approval, monitoring, incident escalation, and retirement. Boards do not need to review every use case, but they do need confidence that management has assigned responsibility and can show evidence of oversight.
Fourth, high-risk AI should require testing and monitoring beyond initial deployment. Models drift. Vendors update features. Internal users stretch tools beyond their intended purpose. Regulation should assume that risk changes over time and require reassessment when systems evolve.
Fifth, organizations should be able to explain how decisions are made. Explainability does not always mean full technical interpretability, especially with complex models. It does mean the organization can describe purpose, inputs, limitations, control points, and when a human is expected to intervene.
Where AI regulation often goes wrong
The biggest mistake is treating AI as a completely separate category of risk. It is new in some ways, but many of the core issues are familiar: privacy, security, third-party dependence, recordkeeping, discrimination, safety, and accountability. The best regulatory models build on those foundations rather than replacing them.
Another mistake is over-focusing on model developers while under-focusing on deployers. The company using an AI system in a regulated workflow carries real responsibility, even if the underlying model comes from a major vendor. If your organization decides to use a tool for claims review, patient communication, hiring, or financial assessment, regulators will not accept vendor branding as a substitute for governance.
There is also a tendency to assume transparency alone solves the problem. It does not. Disclosing that AI is in use is helpful, but it is not enough if the system is unreliable, biased, insecure, or poorly supervised. Transparency is one control, not the governance model.
How should AI be regulated for vendors and third parties?
Third-party AI is where many organizations have the least leverage and the most exposure. That is why AI regulation should place obligations on both providers and customers.
Vendors should be expected to disclose what their systems do, what data they process, where that data goes, what subprocessors are involved, how models are updated, and what security and testing practices they follow. They should also state whether customer data is used for model training, how retention works, and what limitations exist around explainability, access logging, and deletion.
Customers, however, still need to perform due diligence. Procurement and legal review should not stop at standard security questionnaires. AI-specific assessments should examine data flows, output reliability, role-based access, human review requirements, contractual restrictions, and incident notification obligations. For regulated entities, this is not administrative caution. It is a direct part of defensible oversight.
This is especially relevant for healthcare and regulated software companies that depend on external platforms to accelerate adoption. Speed is valuable, but speed without vendor governance usually creates expensive cleanup later.
Regulation should protect rights without freezing adoption
Executives are right to worry about two different failure modes. One is under-regulation, where organizations move quickly and absorb hidden legal, operational, and reputational risk. The other is overcorrection, where fear of scrutiny blocks useful automation and leaves the business slower, more expensive, and less competitive.
The answer is disciplined adoption, supported by clear thresholds. Not every AI use case belongs in the same approval lane. A low-risk internal productivity tool can often move under baseline controls. A customer-facing or decision-support system may require cross-functional review, documented testing, and executive signoff. Regulation should support that kind of proportionality.
Well-designed rules can actually accelerate adoption because they reduce ambiguity. When business teams know what evidence is required, what controls must be in place, and who owns the decision, approvals move faster. Governance is often presented as friction. In mature organizations, it is what allows scale.
What leaders should do now
Leaders do not need to wait for a perfect federal framework to act. They need an internal regulatory posture that can withstand change. That means building governance that is stricter where the stakes are higher and flexible where the risk is limited.
Start with a clear inventory of AI tools, use cases, and vendors. Classify them by impact. Define approval paths, required controls, and documentation standards. Align AI oversight with existing privacy, security, compliance, and third-party risk processes instead of creating a disconnected committee that cannot enforce decisions.
Just as important, make sure governance is visible at the executive level. Boards and senior leaders do not need a technical tutorial. They need a defensible view of where AI is being used, what the highest-risk deployments are, what controls exist, and where management has accepted residual risk. That is the level where trust is built.
For organizations under meaningful regulatory pressure, this is also the point where outside support can add value. Firms like Infragil help translate broad AI concern into practical governance, security, and compliance action that leadership teams can actually operate.
The strongest answer to how should AI be regulated is not stricter by default or lighter by instinct. It is governed according to impact, enforced through real accountability, and documented well enough that leadership can move forward with confidence when the scrutiny arrives.
Ready to Act?
Start Building a Stronger Vendor Risk Program
Skopos gives regulated organizations the tools to manage vendor risk with audit-ready workflows, AI-aware questionnaires, and real-time visibility.